Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tego Science is a leading South Korean biotechnology company specializing in regenerative medicine and cell therapy. The company is a pioneer in the development of cultured skin substitutes, with its flagship products Kaloderm and Holoderm being widely used for the treatment of severe burns and diabetic foot ulcers. Tego Science operates a robust platform for skin cell banking and tissue engineering, and its pipeline includes advanced therapies for rotator cuff repair and aesthetic applications. As a publicly traded entity on the KOSDAQ, Tego Science is a key player in the Asian regenerative medicine market, focusing on both clinical and aesthetic indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TECO Science.